Business Insider
My Markets Watchlist
Markets Stocks

Clover Health Investments Corp Registered Shs -A- Stock , CLOV

2.75 -0.09 -3.00%
09:54:59 AM BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Tuesday morning 06/24/2025 the Clover Health Investments Corp Registered Shs -A- share started trading at the price of $2.86. Compared to the closing price on Monday 06/23/2025 on BTT of $2.84, this is a gain of 0.88%. There are 416.54 M shares outstanding in Clover Health Investments Corp Registered Shs -A-, which values the company at $1.25 B.

Clover Health Investments A Stock Snapshot

2.75
Bid
1,067.00
Bid Size
2.76
Ask
900.00
Ask Size
6/24/2025
Date
9:54 AM
Time
29,080.00
Volume
2.84
Prev. Close
2.86
Open
1.54 B
Market Cap in USD
416.54 M
Number of Shares
508.92 M
Total Number of Shares
2.75
Day Low
2.86
Day High
2.75
1.18
52 Week Low
4.86
52 Week High
2.75
0.00
Dividend in USD
0.00
Dividend Yield
91.77
Free Float in %
-0.09
EPS in USD
0.70
Book Value per Share in USD
0.07
Cash Flow per Share in USD

Historical Prices for Clover Health Investments

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Clover Health Investments Analyst Data

Total Analysts: 2
Buy Ratings: 1 Neutral Ratings: 1 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 1.50 Median: 3.00 Highest: 4.50
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Clover Health Investments Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
03/03/25 Capital Depesche
Maintained Buy $4.5
08/11/23 Citigroup Corp.
Maintained Hold $1.5

Clover Health Investments Estimates* in USD

  2025 2026 2027 2028 2029
Revenue 1,863 2,276 2,564 2,825 3,079
Dividend - - 0.00 - -
Dividend Yield (in %) 0.00 % 0.00 % 0.00 % - -
EPS -0.06 -0.02 0.14 0.28 0.32
P/E Ratio -49.88 -151.38 20.09 10.13 8.86
EBIT -66 -61 -25 8 47
EBITDA 56 88 128 146 175
Net Profit -61 -46 -3 0 32
Net Profit Adjusted 53 58 70 138 159
Pre-Tax Profit -61 -46 -2 8 47
Pre-Tax Profit Reported -59 -50 - - -
EPS (Non-GAAP) ex. SOE 0.11 0.18 0.24 0.28 0.32
EPS (GAAP) -0.12 -0.09 0.00 0.00 0.06
Gross Income 1,837 2,125 - - -
Cash Flow from Investing 7 -3 -4 -4 0
Cash Flow from Operations 14 200 140 139 151
Cash Flow from Financing -32 0 0 0 -127
Cash Flow per Share -0.09 0.00 0.05 - -
Free Cash Flow 36 137 - - -
Free Cash Flow per Share - - - - -
Book Value per Share 0.75 0.98 1.24 - -
Net Debt -200 -334 -447 -653 -676
Research & Development Exp. - - - - -
Capital Expenditure 1 2 2 4 5
Selling, General & Admin. Exp. - - - - -
Shareholder’s Equity 371 475 607 708 740
Total Assets 621 780 932 1,096 1,155
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 4 4 4 4
Average Estimate - -0.009 USD -0.014 USD -0.057 USD -0.019 USD
Year Ago - 0.015 USD -0.019 USD -0.088 USD -
Publish Date - 8/11/2025 11/10/2025 - -
Revenue Estimates
No. of Analysts - 4 4 4 4
Average Estimate - 468 USD 467 USD 1,863 USD 2,276 USD
Year Ago - 356 USD 331 USD 1,371 USD -
Publish Date - 8/11/2025 11/10/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020 2019
Sales 1,370.61 2,028.91 3,486.80 1,538.14 0.12 0.00
Change of sales in % -32.45 -41.81 126.69 1,311,692.25 - -
Gross profit on sales - - - - - -
Gross profit on sales change in % - - - - - -
Operating income -45.98 -187.48 -360.81 -570.85 -6.74 -0.02
Operating income change in % 75.48 48.04 36.79 -8,363.45 -38,155.57 -
Income before tax -46.27 -213.36 -338.84 -587.76 - -0.02
Income before tax change in % 78.32 37.03 42.35 - - -
Income after tax -46.27 -213.36 -338.84 -587.76 -6.74 -0.02
Income after tax change in % 78.32 37.03 42.35 -8,614.16 -38,155.57 -

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020 2019
Total liabilities 239.60 284.28 460.88 411.49 62.91 0.12
Long-term liabilities per share - - - - - -
Equity 341.14 286.39 347.74 539.32 793.51 -0.02
Equity change in % 19.12 -17.64 -35.05 -32.53 - -
Balance sheet total 580.74 570.67 808.62 950.80 856.42 0.10
Balance sheet total change in % 1.76 -29.43 -14.95 11.02 853,367.16 -

Key Data in USD

2024 2023 2022 2021 2020 2019
Sales per share 2.80 4.21 7.32 3.73 0.00 0.00
P/E ratio (year end quote, basic EPS) - - - - - -
P/E ratio (year end quote, diluted EPS) - - - - - -
Dividend yield in % 0.00 0.00 0.00 0.00 0.00 -
Equity ratio in % 58.74 50.19 43.00 56.72 92.65 -17.57
Debt ratio in % 41.26 49.81 57.00 43.28 7.35 117.57

Clover Health Investments Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Reynoso Jamie L. 06/16/2025 20,450.00 3,196,401.00 2.86 Sell No
Soares Karen 06/14/2025 6,404.00 1,256,032.00 2.89 Sell No
Reynoso Jamie L. 06/14/2025 8,691.00 3,216,851.00 2.89 Sell No
Wai Conrad 06/13/2025 98,411.00 3,138,535.00 2.89 Sell No
Reynoso Jamie L. 06/13/2025 12,567.00 3,225,542.00 2.89 Sell No
Kuipers Peter J. 05/18/2025 326,647.00 6,349,973.00 n/a Buy No
Toy Andrew 05/07/2025 85,535.00 10,868,997.00 3.75 Sell No
Reynoso Jamie L. 04/29/2025 25,659.00 3,238,109.00 3.40 Sell No
Wai Conrad 04/29/2025 26,593.00 3,236,946.00 3.40 Sell No
Soares Karen 04/29/2025 27,293.00 1,267,781.00 3.40 Sell No
Priest Brady Patrick 04/29/2025 25,080.00 2,354,810.00 3.40 Sell No
Kuipers Peter J. 04/28/2025 825,989.00 6,023,326.00 3.45 Sell No
Priest Brady Patrick 04/17/2025 38,261.00 2,379,890.00 3.60 Sell No
Reynoso Jamie L. 04/02/2025 6,366.00 3,263,768.00 3.51 Sell No
Toy Andrew 03/31/2025 308,950.00 10,954,532.00 3.59 Sell No
Soares Karen 03/14/2025 4,589.00 1,295,074.00 3.66 Sell No
Reynoso Jamie L. 03/14/2025 6,354.00 3,270,134.00 3.66 Sell No
Wai Conrad 03/13/2025 80,524.00 3,263,539.00 3.66 Sell No
Reynoso Jamie L. 03/13/2025 9,188.00 3,276,488.00 3.66 Sell No
Edwards Carladenise Armbrister 03/06/2025 200,000.00 273,227.00 3.61 Sell No
Priest Brady Patrick 03/05/2025 75,000.00 2,418,151.00 3.68 Sell No
Soares Karen 03/05/2025 52,500.00 1,299,663.00 3.80 Sell No
Toy Andrew 02/07/2025 85,535.00 11,263,482.00 4.32 Sell No
Wai Conrad 01/30/2025 24,470.00 3,344,063.00 4.39 Sell No
Priest Brady Patrick 01/30/2025 18,987.00 2,493,151.00 4.39 Sell No

Clover Health Investments A Dividend Calendar

Date Name Dividend *yield Currency
2024 Clover Health Investments Corp Registered Shs -A- 0.00 0.00 USD
2023 Clover Health Investments Corp Registered Shs -A- 0.00 0.00 USD
2022 Clover Health Investments Corp Registered Shs -A- 0.00 0.00 USD
2021 Clover Health Investments Corp Registered Shs -A- 0.00 0.00 USD
2020 Clover Health Investments Corp Registered Shs -A- 0.00 0.00 USD
2019 Clover Health Investments Corp Registered Shs -A- - - USD
*Yield of the Respective Date

Clover Health Investments A Calendar

Event Estimate Info Date
Earnings Report -0.009 USD Q2 2025 Earnings Release 08/11/2025
Earnings Report -0.014 USD Q3 2025 Earnings Release 11/10/2025
Earnings Report -0.043 USD Q4 2025 Earnings Release 03/04/2026
Earnings Report 0.020 USD Q1 2026 Earnings Release 05/12/2026

Clover Health Investments A Past Events

Event Actual EPS Info Date
Annual General Meeting -0.088 USD Annual General Meeting 06/10/2025
Earnings Report -0.003 USD Q1 2025 Earnings Release 05/06/2025
Earnings Report -0.045 USD Q4 2024 Earnings Release 02/27/2025
Earnings Report -0.019 USD Q3 2024 Earnings Release 11/06/2024
Earnings Report 0.015 USD Q2 2024 Earnings Release 08/05/2024
Annual General Meeting -0.440 USD Annual General Meeting 06/10/2024
Earnings Report -0.039 USD Q1 2024 Earnings Release 05/07/2024
Earnings Report -0.140 USD Q4 2023 Earnings Release 03/12/2024
Earnings Report -0.086 USD Q3 2023 Earnings Release 11/06/2023
Earnings Report -0.060 USD Q2 2023 Earnings Release 08/08/2023
Annual General Meeting -0.710 USD Annual General Meeting 06/07/2023
Earnings Report -0.152 USD Q1 2023 Earnings Release 05/09/2023
Earnings Report -0.170 USD Q4 2022 Earnings Release 02/28/2023
Earnings Report -0.158 USD Q3 2022 Earnings Release 11/07/2022
Annual General Meeting -1.420 USD Annual General Meeting 09/22/2022
Earnings Report -0.219 USD Q2 2022 Earnings Release 08/08/2022
Earnings Report -0.159 USD Q1 2022 Earnings Release 05/09/2022
Earnings Report -0.440 USD Q4 2021 Earnings Release 02/23/2022

Clover Health Investments Profile

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.
OSZAR »